Business Today
Loading...

COVID-19: Defence Minister to release first batch of DRDO's 2-DG drug on Monday

The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence.

twitter-logoBusinessToday.In | May 16, 2021 | Updated 21:59 IST
COVID-19: Defence Minister to release first batch of DRDO's 2-DG drug on Monday
The 2-DG drug has been developed by the Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy's Laboratories.

The first batch of Defence Research and Development Organisation's (DRDO) anti-COVID drug 2-DG will be released on Monday by Defence Minister Rajnath Singh.

In a tweet, the Office of Defence Minister said the first batch of 2-DG will be released via video conferencing facility at 10:30 AM on Monday.

Also read: COVID-19: Covaxin protects against all key emerging virus variants, says Bharat Biotech

The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.

The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence.

The PM CARES Fund had on May 12 also approved the procurement of 1,50,000 units of oxycare system developed by DRDO at a cost of Rs 322.5 crore. Oxycare is a SpO2 based oxygen supply system which regulates the oxygen being administered to patients based on the sensed SpO2 levels.

Under the sanction, 1,00,000 manual and 50,000 automatic oxycare systems along with non-rebreather masks are being procured, the defence ministry said in a release.  

Also read: COVID-19: Remdesivir to be supplied directly to private hospitals, says Tamil Nadu govt

  • Print
  • COMMENT
BT-Story-Page-B.gif
A    A   A
close